EXPERIENCE IN MANAGING PATIENTS OF REPRODUCTIVE AGE WITH DYSHORMONAL DISEASES OF THE MAMMARY GLANDS

This article presents the results of own research of the Indol-F® efficacy and safety in the treatment of 86 patients of reproductive age with a dysplasia of mammary glands for 3 months. Comparison was carried out with 50 women who were under dynamic observation. Improvement of mammary glands status (by a set of attributes) on treatment with Indole-F® was observed in 75,6% of patients, menstrual function normalization in 63,3% of patients. At the same time, spontaneous progression of symptoms was noted in more than a half of patients in the observation group.